• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子工程化的减毒活嵌合西尼罗河/登革热病毒疫苗可保护恒河猴免受西尼罗河病毒感染。

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.

作者信息

Pletnev Alexander G, Claire Marisa St, Elkins Randy, Speicher Jim, Murphy Brian R, Chanock Robert M

机构信息

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Virology. 2003 Sep 15;314(1):190-5. doi: 10.1016/s0042-6822(03)00450-1.

DOI:10.1016/s0042-6822(03)00450-1
PMID:14517072
Abstract

Two molecularly engineered, live-attenuated West Nile virus (WN) vaccine candidates were highly attenuated and protective in rhesus monkeys. The vaccine candidates are chimeric viruses (designated WN/DEN4) bearing the membrane precursor and envelope protein genes of WN on a backbone of dengue 4 virus (DEN4) with or without a deletion of 30 nucleotides (Delta 30) in the 3' noncoding region of DEN4. Viremia in WN/DEN4- infected monkeys was reduced 100-fold compared to that in WN- or DEN4-infected monkeys. WN/DEN4-3'Delta 30 did not cause detectable viremia, indicating that it is even more attenuated for monkeys. These findings indicate that chimerization itself and the presence of the Delta 30 mutation independently contribute to the attenuation phenotype for nonhuman primates. Despite their high level of attenuation in monkeys, the chimeras induced a moderate-to-high titer of neutralizing antibodies and prevented viremia in monkeys challenged with WN. The more attenuated vaccine candidate, WN/DEN4-3'Delta 30, will be evaluated first in our initial clinical studies.

摘要

两种经过分子工程改造的西尼罗河病毒(WN)减毒活疫苗候选株在恒河猴中高度减毒且具有保护作用。这些疫苗候选株是嵌合病毒(命名为WN/DEN4),其在登革热4型病毒(DEN4)的骨架上携带WN的膜前体蛋白和包膜蛋白基因,DEN4的3'非编码区有或没有30个核苷酸的缺失(Δ30)。与WN或DEN4感染的猴子相比,WN/DEN4感染的猴子的病毒血症降低了100倍。WN/DEN4-3'Δ30未引起可检测到的病毒血症,表明它对猴子的减毒作用更强。这些发现表明,嵌合化本身和Δ30突变的存在独立地导致了非人灵长类动物的减毒表型。尽管这些嵌合病毒在猴子中高度减毒,但它们诱导了中到高滴度的中和抗体,并在WN攻击的猴子中预防了病毒血症。减毒作用更强的疫苗候选株WN/DEN4-3'Δ30将在我们最初的临床研究中首先进行评估。

相似文献

1
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.分子工程化的减毒活嵌合西尼罗河/登革热病毒疫苗可保护恒河猴免受西尼罗河病毒感染。
Virology. 2003 Sep 15;314(1):190-5. doi: 10.1016/s0042-6822(03)00450-1.
2
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.嵌合登革热2型PDK-53/西尼罗河病毒NY99保留了候选PDK-53疫苗病毒的表型减毒标记,并保护小鼠免受西尼罗河病毒致死性攻击。
J Virol. 2005 Jun;79(12):7300-10. doi: 10.1128/JVI.79.12.7300-7310.2005.
3
Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.嵌合西尼罗河/登革病毒候选疫苗:在小鼠、鹅和猴子中进行的安全性和免疫原性临床前评估。
Vaccine. 2006 Sep 29;24(40-41):6392-404. doi: 10.1016/j.vaccine.2006.06.008. Epub 2006 Jun 21.
4
Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.西尼罗河/登革嵌合病毒对西尼罗河和登革热蚊媒的感染性。
Vector Borne Zoonotic Dis. 2005 Spring;5(1):1-10. doi: 10.1089/vbz.2005.5.1.
5
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.西尼罗河病毒/登革热4型病毒嵌合体,其神经毒性和外周毒性降低,且不丧失免疫原性或保护效力。
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3036-41. doi: 10.1073/pnas.022652799.
6
Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.蜱传兰加特病毒/蚊传登革热黄病毒嵌合体,一种用于预防蜱传脑炎病毒复合体成员所致疾病的减毒活疫苗候选物:在恒河猴和蚊子中的评估
J Virol. 2001 Sep;75(17):8259-67. doi: 10.1128/jvi.75.17.8259-8267.2001.
7
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.重组嵌合黄热-登革2型病毒在非人灵长类动物中具有免疫原性和保护性。
J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000.
8
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.用登革2型病毒的结构基因替换登革4型病毒的结构基因,可产生嵌合疫苗候选株,这些候选株在蚊子、小鼠和恒河猴中表现出减毒特性。
Vaccine. 2003 Oct 1;21(27-30):4307-16. doi: 10.1016/s0264-410x(03)00488-2.
9
Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.小鼠和恒河猴中圣路易斯脑炎病毒/登革4型病毒抗原嵌合病毒的评估
Vaccine. 2008 Aug 5;26(33):4150-9. doi: 10.1016/j.vaccine.2008.05.075. Epub 2008 Jun 13.
10
Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.针对西尼罗河病毒的减毒活疫苗的神经毒性保证:与两种亲本病毒和一种黄病毒替代参考疫苗相比,对嵌合WN/DEN4Δ30疫苗感染后的神经发病机制进行的综合研究。
Vaccine. 2014 May 30;32(26):3187-97. doi: 10.1016/j.vaccine.2014.04.002. Epub 2014 Apr 13.

引用本文的文献

1
Subgenomic flavivirus RNA as key target for live-attenuated vaccine development.亚基因组黄病毒 RNA 作为减毒活疫苗开发的关键靶标。
J Virol. 2024 Jul 23;98(7):e0010023. doi: 10.1128/jvi.00100-23. Epub 2024 May 29.
2
A Perspective on Current Flavivirus Vaccine Development: A Brief Review.当前黄病毒疫苗开发的观点:简要综述。
Viruses. 2023 Mar 28;15(4):860. doi: 10.3390/v15040860.
3
Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses.基于新型昆虫特异性黄病毒的嵌合疫苗。
Vaccines (Basel). 2021 Oct 22;9(11):1230. doi: 10.3390/vaccines9111230.
4
Current Progress of Avian Vaccines Against West Nile Virus.禽用西尼罗河病毒疫苗的当前进展
Vaccines (Basel). 2019 Sep 23;7(4):126. doi: 10.3390/vaccines7040126.
5
A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.一种减毒活嵌合西尼罗河病毒疫苗rWN/DEN4Δ30,在未感染黄病毒的老年志愿者中耐受性良好且具有免疫原性。
J Infect Dis. 2017 Jan 1;215(1):52-55. doi: 10.1093/infdis/jiw501. Epub 2016 Oct 25.
6
An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.西尼罗河病毒感染治疗与预防的当前方法概述
Methods Mol Biol. 2016;1435:249-91. doi: 10.1007/978-1-4939-3670-0_19.
7
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.一种新型合成TLR-4激动剂佐剂可增强多种配方的临床阶段西尼罗河病毒疫苗抗原的保护性反应。
PLoS One. 2016 Feb 22;11(2):e0149610. doi: 10.1371/journal.pone.0149610. eCollection 2016.
8
Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus.实验性感染欧洲型西尼罗河病毒的恒河猴和普通狨猴。
PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2797. doi: 10.1371/journal.pntd.0002797. eCollection 2014 Apr.
9
Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.针对西尼罗河病毒的减毒活疫苗的神经毒性保证:与两种亲本病毒和一种黄病毒替代参考疫苗相比,对嵌合WN/DEN4Δ30疫苗感染后的神经发病机制进行的综合研究。
Vaccine. 2014 May 30;32(26):3187-97. doi: 10.1016/j.vaccine.2014.04.002. Epub 2014 Apr 13.
10
Current trends in West Nile virus vaccine development.西尼罗河病毒疫苗研发的最新趋势。
Expert Rev Vaccines. 2014 May;13(5):589-608. doi: 10.1586/14760584.2014.906309. Epub 2014 Apr 1.